NCT06030947 Effectiveness of Micro Connective Tissue Graft for Treatment of Multiple Adjacent Gingival Recession Defects
| NCT ID | NCT06030947 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Gingival Recession, Localized |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2026-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-03-01 with a primary completion date of 2026-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this project is to evaluate 1-year outcomes of treatment of MAGRD using a modified coronally advanced tunnel technique (MCAT) with either conventional CTG (control group) or micro-CTG (test group).
Eligibility Criteria
Inclusion Criteria: * age ≥18 years, * systemically healthy, * presenting with a minimum of 4 and a maximum of 6 adjacent RT1/RT2 recessions, located in the maxilla or mandible with an apico-coronal extension (i.e. recession depth) of ≥2 mm, * Full-Mouth Plaque Score (FMPS) \<20%, * Full-Mouth Bleeding Score (FMBS) \<20%. Exclusion Criteria: * pregnancy or lactation, * tobacco smoking, * uncontrolled medical condition, * medication that can affect gingival conditions. * thick phenotype, * severe tooth malpositioning, * uncorrected trauma from toothbrushing, * a previous history of root coverage procedures * the presence of furcation defects.
Contact & Investigator
Jan Derks, DDS, PhD
STUDY CHAIR
Goteborg University
Frequently Asked Questions
Who can join the NCT06030947 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Gingival Recession, Localized. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06030947 currently recruiting?
Yes, NCT06030947 is actively recruiting participants. Contact the research team at olivier.carcuac@gu.se for enrollment information.
Where is the NCT06030947 trial being conducted?
This trial is being conducted at Dubai, United Arab Emirates.
Who is sponsoring the NCT06030947 clinical trial?
NCT06030947 is sponsored by Göteborg University. The principal investigator is Jan Derks, DDS, PhD at Goteborg University. The trial plans to enroll 30 participants.